Takuya Tsunoda
Keine laufenden Positionen mehr
Profil
Dr. Takuya Tsunoda, MD PhD, is President & Representative Director at Immunas Pharma, Inc. and President & Representative Director at OncoTherapy Science, Inc. He is on the Board of Directors at Immunas Pharma, Inc. and OncoTherapy Science, Inc.
Dr. Tsunoda was previously employed as an Assistant Research Scientist by City of Hope.
He received his undergraduate degree from Wakayama Medical University and a doctorate degree from Wakayama Medical University.
Ehemalige bekannte Positionen von Takuya Tsunoda
| Unternehmen | Position | Ende |
|---|---|---|
City of Hope National Cancer Institute
 City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Präsident | - |
| ONCOTHERAPY SCIENCE, INC. | Präsident | - |
Ausbildung von Takuya Tsunoda
| Wakayama Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
City of Hope National Cancer Institute
City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA. | Health Services |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
